Next 10 |
2024-04-15 02:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-10 10:11:36 ET Summary Entravision Communications' stock has dropped about 50% due to the loss of their contract with Meta Platforms. The company has invested around $100 million in digital M&A, but digital margins have been shrinking. The value of Entravision's TV...
Extensive Phase I immunology data confirm strong immunogenicity of TG4050 in the adjuvant treatment of head and neck cancers. All treated patients remain disease-free after a median follow-up of 18.6 months. Phase II part of the trial to start enrolling patients in coming weeks. ...
2024-04-03 02:21:05 ET Summary TEGNA has announced a capital allocation strategy to boost performance, including a $800 million share repurchase program and a 20% increase in dividends. The company has renewed its contractual obligations, focusing on content generation, customer e...
2023 Full-year results and business update Lead program TG4050 to deliver data in 2024. Advancements in other clinical programs and Research and Innovation (R&I) activity to deliver news flow and fuel growth in Transgene’s portfolio over the next 24 month...
Strasbourg, France, March 27, 2024, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, is pleased to announce the appointment of Lucie Larguier as Chief Financial Officer (CFO), effect...
2024-03-26 03:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
TEGNA Inc. (NYSE: TGNA) will host a conference call to discuss its first quarter 2024 earnings results on Wednesday, May 8, 2024, at 10 a.m. (ET). The conference call will be webcast through the company’s website , and is open to investors, the financial community, the media and ot...
2024-03-06 08:00:13 ET TEGNA Inc (TGNA) declaring a stock dividend of $0.11375 per share on Ex-Date : March 07, 2024. Shareholders on record as of March 08, 2024 are eligible for the dividend. The payment date is scheduled for April 01, 2024, and the declaration was officially made ...
Poster presentation of new data from ongoing randomized Phase I trial targeting head and neck cancers Strasbourg, France, March 6, 2024, 7:30 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for t...
News, Short Squeeze, Breakout and More Instantly...
2024-04-15 02:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Extensive Phase I immunology data confirm strong immunogenicity of TG4050 in the adjuvant treatment of head and neck cancers. All treated patients remain disease-free after a median follow-up of 18.6 months. Phase II part of the trial to start enrolling patients in coming weeks. ...
2023 Full-year results and business update Lead program TG4050 to deliver data in 2024. Advancements in other clinical programs and Research and Innovation (R&I) activity to deliver news flow and fuel growth in Transgene’s portfolio over the next 24 month...